Paraganglioma — Trials

Paraganglioma — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01377532	Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma	approved for marketing	—	—	University of California, San FranciscoOTHER	1	May 6, 2020	clinicaltrials
NCT02961491	Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma	approved for marketing	—	—	Molecular Insight Pharmaceuticals, Inc.INDUSTRY	1	Jan 30, 2019